Researchers with the BC Cancer Agency’s Genome Sciences Centre developed two new approaches – ALEXASeq and Trans-ABySS – to characterize how the information in genes is expressed. These modes represent significant steps towards cost-effective surveying of all genetic information in a tumour, moving us closer to personalized medicine.